One found only a small increased risk of NAION among GLP-1 users: 35 patients out of 159,000 (0.04%) developed NAION, compared to 19 patients (0.02%) in the control group
The write-up also captures that, although the number of adverse event mentions rose over time, the proportion of posts focusing on side effects declined, reflecting a shift in online conversations toward other aspects of these drugs
G., Grusdat, M
This includes ensuring youre eating enough calories, protein, and micronutrient-dense foods
For a crunchy coating, use crushed nuts or protein chips instead of flour, breadcrumbs, or panko
Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Huang Y, He Y, Makarcyzk MJ, Lin H Frontiers in Bioengineering and Biotechnology (2021) This study demonstrated that FOXO4-DRI selectively removes senescent cells from human chondrocyte cultures expanded in vitro, providing direct evidence of the peptide's senolytic activity in human cells relevant to joint and cartilage aging
